
 |
| New Medicines in Development for Women |
 |
 |
|
|
United States |
|
Dr. Donnica discusses the different types of ongoing research for women's health and how women can become involved in clinical trials.
|
 |
| Url: |
|
| Desc: |
New Medicines In Development For Women - DrDonnica.com - The First Name in Women's Health
|
| |
Read about advancements in development of medicines for women's health issues.
|
| Category: |
Pharmacy\ Drugs and Medications
|
| Link Error: |
Report It
|
| |
|
|
|
| Related Site |
 |
 |
Generic Medications : A safe and secure place to buy wide range of generic medications at cheap price – Generic Medication Online.
Health Care Consulting – Smart Consulting Group LLC : At Smart Consulting we offer health care consulting services.
Medical Expert : Informational website dedicated to health and medicine. Drugs reviews and comparisons, Brand/Generic name correspondence tool, PDR's Side effects index. The information is based on recent reviews and articles published in the medical literature and drug prescribing
information approved by the US FDA.
Drug Side Effects & Clinical Trials : Offering in-depth information about the side effects of individual medications in clear, understandable and always medically relevant layman’s terms, as well as information about clinical trials, all with a touch of humor and light-heartedness. Also offers direct interaction with a licensed clinical pharmacist.
natural breast enhancement pills : Natural breast enhancement pills for natural Breast Enlargement and permanent natural breast enhancement without surgery. Breast Intense breast pills are completely natural and healthy and based on the herb of hop
Tracrium (Atracurium Besylate) - RxList Monographs : TRACRIUM (atracurium besylate) is an intermediate-duration, nondepolarizing, skeletal muscle relaxant for intravenous administration. Atracurium besylate is designated as 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4- dimethoxyphenyl) methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium]dibenzenesulfonate.
Atracurium besylate is a complex molecule containing four sites at which different stereochemical configurat
Hismanal (Astemizole) - RxList Monographs : Hismanal (astemizole) is a histamine H1-receptor antagonist available in scored white tablets for oral use. Each tablet contains 10 mg of astemizole, and as inactive ingredients: lactose, cornstarch, microcrystalline cellulose, pregelatinized starch, povidone K90, magnesium stearate, colloidal silicon dioxide, and sodium lauryl sulfate. Astemizole is chemically designated as 1-[(4-fluorophenyl) -methyl] -N-[1-[2-(4-methoxyphenyl) ethyl]-4 -piperi
Argatroban - RxList Monographs : Argatroban is a synthetic direct thrombin inhibitor derived from L- arginine. The chemical name for Argatroban is 1-[5-[(aminoiminomethyl)-amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl) sulfonyl]-amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate.
Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban co
Malarone : There are four types of malaria. MALARONE is approved for the treatment and prevention of Plasmodium falciparum malaria in adults and children weighing at least 25 lbs.
In studies conducted for the prevention of malaria in adults, the most common side effects possibly attributed to MALARONE versus placebo were headache (5% vs. 7%) and abdominal pain (3% vs. 5%), in pediatric patients, headache (14% vs. 14%), abdominal pain (31% vs. 29%), and v
Thrombate : Antithrombin III (Human), THROMBATE III® is a sterile, nonpyrogenic, stable, lyophilized preparation of purified human antithrombin III.
THROMBATE III is prepared from pooled units of human plasma from normal donors by modifications and refinements of the cold ethanol method of Cohn.1 When reconstituted with Sterile Water for Injection, USP, THROMBATE III has a pH of 6.0-7.5, a sodium content of 110-210 mEq/L, a chloride content of 110-210 mE
|
|
|
 |
 |
 |
Many High-Risk Women Refuse Breast MRI (HealthDay)
HealthDay - TUESDAY, Dec. 22 (HealthDay News) -- For women at high risk of breast
cancer, an MRI can help detect malignancies early and is often suggested
in addition to annual mammograms. Yet, 42 percent of such women in a new
study said no to the test. |
|
|
 |